World Library  


Add to Book Shelf
Flag as Inappropriate
Email this Book

Plos One : an Antimitotic and Antivascular Agent Bpr0L075 Overcomes Multidrug Resistance and Induces Mitotic Catastrophe in Paclitaxel-resistant Ovarian Cancer Cells, Volume 8

By Wang, Qiang

Click here to view

Book Id: WPLBN0003943708
Format Type: PDF eBook :
File Size:
Reproduction Date: 2015

Title: Plos One : an Antimitotic and Antivascular Agent Bpr0L075 Overcomes Multidrug Resistance and Induces Mitotic Catastrophe in Paclitaxel-resistant Ovarian Cancer Cells, Volume 8  
Author: Wang, Qiang
Volume: Volume 8
Language: English
Subject: Journals, Science, Medical Science
Collections: Periodicals: Journal and Magazine Collection (Contemporary)
Historic
Publication Date:
Publisher: Plos

Citation

APA MLA Chicago

Wang, Q. (n.d.). Plos One : an Antimitotic and Antivascular Agent Bpr0L075 Overcomes Multidrug Resistance and Induces Mitotic Catastrophe in Paclitaxel-resistant Ovarian Cancer Cells, Volume 8. Retrieved from http://netlibrary.net/


Description
Description : Paclitaxel plays a major role in the treatment of ovarian cancer: however, resistance to paclitaxel is frequently observed. Thus, new therapy that can overcome paclitaxel resistance will be of significant clinical importance. We evaluated antiproliferative effects of an antimitotic and antivascular agent BPR0L075 in paclitaxel-resistant ovarian cancer cells. BPR0L075 displays potent and broad-spectrum cytotoxicity at low nanomolar concentrations (IC50 = 2–7 nM) against both parental ovarian cancer cells (OVCAR-3, SKOV-3, and A2780-1A9) and paclitaxel-resistant sublines (OVCAR-3-TR, SKOV-3-TR, 1A9-PTX10), regardless of the expression levels of the multidrug resistance transporter P-gp and class III b-tubulin or mutation of b-tubulin. BPR0L075 blocks cell cycle at the G2/M phase in paclitaxel-resistant cells while equal concentration of paclitaxel treatment was ineffective. BPR0L075 induces cell death by a dual mechanism in parental and paclitaxel-resistant ovarian cancer cells. In the parental cells (OVCAR-3 and SKOV-3), BPR0L075 induced apoptosis, evidenced by poly(ADPribose) polymerase (PARP) cleavage and DNA ladder formation. BPR0L075 induced cell death in paclitaxel-resistant ovarian cancer cells (OVCAR-3-TR and SKOV-3-TR) is primarily due to mitotic catastrophe, evidenced by formation of giant, multinucleated cells and absence of PARP cleavage. Immunoblotting analysis shows that BPR0L075 treatment induced upregulation of cyclin B1, BubR1, MPM-2, and survivin protein levels and Bcl-XL phosphorylation in parental cells: however, in resistant cells, the endogenous expressions of BubR1 and survivin were depleted, BPR0L075 treatment failed to induce MPM-2 expression and phosphorylation of Bcl-XL. BPR0L075 induced cell death in both parental and paclitaxel-resistant ovarian cancer cells proceed through caspase-3 independent mechanisms. In conclusion, BPR0L075 displays potent cytotoxic effects in ovarian cancer cells with a potential to overcome paclitaxel resistance by bypassing efflux transporters and inducing mitotic catastrophe. BPR0L075 represents a novel microtubule therapeutic to overcome multidrug resistance and trigger alternative cell death by mitotic catastrophe in ovarian cancer cells that are apoptosis-resistant.

 

Click To View

Additional Books


  • Plos One : Induction of Porcine Host Def... (by )
  • Plos One : Characteristics of Latrines i... (by )
  • Plos One : Thioredoxin-1 Attenuates Earl... (by )
  • Plos One : Identifying Parameters to Dis... (by )
  • Plos One : Cell Surface Glycan Alteratio... (by )
  • Plos One : Developmental Trajectories of... (by )
  • Plos One : the Periglomerular Cell of th... (by )
  • Plos One : Epithelial Mesenchymal Transi... (by )
  • Plos One : the Critical Role of Astragal... (by )
  • Plos One : Adaptation to Shift Work ; Ph... (by )
  • Plos One : the Roles of Noradrenergic an... (by )
  • Plos One : Identification of Global Alte... (by )
Scroll Left
Scroll Right

 



Copyright © World Library Foundation. All rights reserved. eBooks from World Library are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.